RT
The startup has developed a genome editing platform utilizing a novel PGI method to insert and delete specific DNA sequences. This technology targets life-threatening genetic diseases, enabling doctors to treat conditions like cancer and improve patient health outcomes.
Updated 4 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup has developed a genome editing platform utilizing a novel PGI method to insert and delete specific DNA sequences. This technology targets life-threatening genetic diseases, enabling doctors to treat conditions like cancer and improve patient health outcomes.